Frequency of Evidence-Based Screening for Retinopathy in Type 1 Diabetes | Zendy

David M. Nathan | Zendy; Ionut Bebu | Zendy; Dean P. Hainsworth | Zendy; Ronald Klein | Zendy; William V. Tamborlane | Zendy; Gayle M. Lorenzi | Zendy; Rose GubitosiKlug | Zendy; John M. Lachin | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Frequency of Evidence-Based Screening for Retinopathy in Type 1 Diabetes

Author(s) -

David M. Nathan,

Ionut Bebu,

Dean P. Hainsworth,

Ronald Klein,

William V. Tamborlane,

Gayle M. Lorenzi,

Rose GubitosiKlug,

John M. Lachin

Publication year - 2017

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa1612836

Subject(s) - medicine , diabetic retinopathy , retinopathy , diabetes mellitus , type 1 diabetes , macular edema , ophthalmology , retinal , psychological intervention , epidemiology , optometry , intervention (counseling) , pediatrics , endocrinology , psychiatry

In patients who have had type 1 diabetes for 5 years, current recommendations regarding screening for diabetic retinopathy include annual dilated retinal examinations to detect proliferative retinopathy or clinically significant macular edema, both of which require timely intervention to preserve vision. During 30 years of the Diabetes Control and Complications Trial (DCCT) and its longitudinal follow-up Epidemiology of Diabetes Interventions and Complications (EDIC) study, retinal photography was performed at intervals of 6 months to 4 years.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research